Pre-Approval Access to Esketamine Nasal Spray for the Treatment of Treatment-Resistant Depression (TRD)
Clinical trial NCT03829579 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT03829579
- Sponsor
- Janssen Research & Development, LLC
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.